The association with low IGF-1 is consistent with prior work suggesting that many people with adult-onset growth hormone deficiency exhibit an MDD phenotype that is responsive to growth hormone therapy [32] though the observation that MDD patients often have high IGF-1 levels [33–36] suggests that IGF-1 dysregulation in either direction may be harmful. This evidence concerns the gene IGF1 and major depressive disorder.